Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             110 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of primary cutaneous aggressive epidermotropic CD8+ Cytotoxic T-cell lymphoma Dizman, Didem
2018
101 S1 p. S18
artikel
2 Adverse bystander effect of localized electron beam irradiation–A negative abscopal effect? Moritz, Rose
2018
101 S1 p. S33
artikel
3 Aggressive rare T cell lymphomas with manifestation in the skin: A monocentric cross-sectional case study Brüggen, Marie-Charlotte
2018
101 S1 p. S18-S19
artikel
4 ALK-positive large B-cell lymphoma - report of the first primary cutaneous case Kempf, Werner
2018
101 S1 p. S25
artikel
5 Allogeneic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: 2018 update of the Milan experience Onida, Francesco
2018
101 S1 p. S35-S36
artikel
6 Anaplastic large cell lymphoma in an organ transplant recipient Osmancevic, Amra
2018
101 S1 p. S27
artikel
7 Angioimmunoblastic-T-cell-lymphoma mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Mangana, Ioanna
2018
101 S1 p. S23
artikel
8 An iatrogenic EBV-positive cutaneous anaplastic large cell lymphoma with BRAF V600E mutations Gru, Alejandro
2018
101 S1 p. S26
artikel
9 An integrated data resource for genomic analysis of cutaneous T-cell lymphoma Geskin, Larisa
2018
101 S1 p. S15
artikel
10 A novel approach to low dose total skin electron beam therapy (TSEBT) Suhail, Taqdees
2018
101 S1 p. S31
artikel
11 A retrospective analysis of clinicopathologic features and treatment response rates in patients with folliculotropic mycosis fungoides in a series of 29 cases Sahu, Joya
2018
101 S1 p. S37-S38
artikel
12 Atypical mycosis fungoides in a 51- year old woman with previous Hodgkin lymphoma Väkevä, Liisa
2018
101 S1 p. S21
artikel
13 Clinical experience with multimodality therapy and extracorporeal photopheresis in patients with cutaneous T-cell lymphoma, retrospective descriptive study in the Italian Hospital of Buenos Aires Baquero Rey, Jenny Andrea
2018
101 S1 p. S33
artikel
14 Clinical status of Mycosis fungoides in 636 Greek patients Sidiropoulou, Polytimi
2018
101 S1 p. S19
artikel
15 Clinicopathologic characteristics, prognostic and predictive biomarkers in adult T-cell leukemia/lymphoma (ATLL): A characterization of 79 cases from the Western Hemisphere Gru, Alejandro
2018
101 S1 p. S16
artikel
16 Clonal diversity of mycosis fungoides, a mature T-cell lymphoma Hamrouni, Abdelbasset
2018
101 S1 p. S4
artikel
17 Contents 2018
101 S1 p. iv
artikel
18 Cost of early-stage mycosis fungoides treatments in Spain Ortiz-Romero, Pablo Luis
2018
101 S1 p. S30
artikel
19 CTCL cell line cells secrete extracellular vesicles containing HERV-W-coded fusogenic syncytin-1 Laukkanen, Kirsi
2018
101 S1 p. S10
artikel
20 Cutaneous lymphoma of small and medium medium CD4 positive cells: A report of three cases of a rare disease Miranda, Andrea Andrade
2018
101 S1 p. S17
artikel
21 Cutaneous T-cell lymphoma and paraneoplastic syndromes: A case report and literature review Queen, Dawn
2018
101 S1 p. S20
artikel
22 Cytokine profile alterations in Cutaneous T-cell Lymphoma cell lines after Lenalidomide and/or Bortezomib treatment Bakou, Vassiliki
2018
101 S1 p. S13
artikel
23 Diagnostic approach to extranodal NK/T-cell lymphomas using a rare case of non-nasal type extranodal NK/T-cell lymphoma with gamma/delta-T-cell phenotype Lamos, Cristina
2018
101 S1 p. S23
artikel
24 Differences in the miRNA expression profiles of erythrodermic mycosis fungoides and Sézary syndrome Rittig, Anne Hald
2018
101 S1 p. S3-S4
artikel
25 Differential expression of TOX in hypopigmented and classical mycosis fungoides Ibrahim, Mona
2018
101 S1 p. S3
artikel
26 Different outcomes for two male patients with Sézary syndrome Osmancevic, Amra
2018
101 S1 p. S35
artikel
27 Does treatment with anti-tumor necrosis factor alpha have an effect on primary cutaneous lymphoma? Amitay-Laish, Iris
2018
101 S1 p. S30
artikel
28 Dysregulation of the expression of antimicrobial peptides in patients with cutaneous T-cell lymphoma Wehkamp, Ulrike
2018
101 S1 p. S15-S16
artikel
29 Establishment of an in vivo model of patient-derived SS for therapy validation Espinosa, Lluis
2018
101 S1 p. S13
artikel
30 Experimental modifications lead to an improved SNV detection in panel sequencing of a mycosis fungoides patient Hain, Carsten
2018
101 S1 p. S14-S15
artikel
31 Expression of TIGIT, BTLA, LAG3, FCRL3 and CTLA-4 in Sézary Syndrome Anzengruber, Florian
2018
101 S1 p. S5
artikel
32 18F-FDG-PET/CT for staging mycosis fungoides and Sezary syndrome Grandi, Vieri
2018
101 S1 p. S34-S35
artikel
33 Frequency of associated haematologic malignancies in lymphomatoid papulosis: A preliminary report of 505 patients from the Dutch Cutaneous Lymphoma Group Melchers, Rutger
2018
101 S1 p. S6
artikel
34 Functional interrogation of STAT5 variants in Primary Cutaneous T-cell Lymphoma (CTCL) Butler, Rosie
2018
101 S1 p. S12
artikel
35 Genomic alterations using OncoScan in adult T-cell leukemia/lymphoma: A characterization of 69 cases from Peru, the United States, Brazil, and Spain Davick, Jonathan
2018
101 S1 p. S15
artikel
36 Genomic analysis reveals recurrent deletion of HNRNPK and SOCS1 in mycosis fungoides Torres, Armando Bastidas
2018
101 S1 p. S7
artikel
37 Granulomatous mycosis fungoides, with features of granulomatous slack skin. Co-morbidity with several visceral cancers, indolent course of the skin disease. Disparity of clinical picture and histopathology Inerot, Annica
2018
101 S1 p. S23-S24
artikel
38 Granulomatous slack skin: A series of cases Miotto, Isadora
2018
101 S1 p. S25
artikel
39 Health-related quality of life in cutaneous lymphomas: A state-of-the-art review Porkert, Stefanie
2018
101 S1 p. S39-S40
artikel
40 HLA I shield tumor skin T lymphocytes from NK-cell-mediated elimination Chang, Yun-Tsan
2018
101 S1 p. S7
artikel
41 Hydroa vacciniforme and hydroa vacciniforme-like lymphoproliferative disorder: Disease spectrum, responsible T-cell subsets and prognosis Iwatsuki, Keiji
2018
101 S1 p. S40
artikel
42 Identification of predictive markers for stage progression in primary cutaneous anaplastic large cell lymphoma Yoo, Jin Ah
2018
101 S1 p. S8
artikel
43 Identifying intratumor heterogeneity in mycosis fungoides using high throughput DNA sequencing Iyer, Aishwarya
2018
101 S1 p. S2-S3
artikel
44 Indolent cytotoxic cutaneous lymphomas with clinical and histological features of atypical lymphoid proliferation not otherwise specified. Alberti-Violetti, Silvia
2018
101 S1 p. S22-S23
artikel
45 Indolent hematodermic CD4+ T-cell lymphoma lacking surface CD3 expression: Structural and functional deficiency of T-cell receptor/CD3 complex Iwatsuki, Keiji
2018
101 S1 p. S24
artikel
46 Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in a mycosis fungoides patient with central nervous system involvement Dörschner, Miriam
2018
101 S1 p. S19
artikel
47 Intralesional Injection of the CD47-blocking immune checkpoint inhibitor TTI-621 (SIRPaFc) induces antitumor activity in patients with relapsed/refractory mycosis fungoides and Sézary syndrome: Interim results of a multicenter Phase 1 trial Querfeld, Christiane
2018
101 S1 p. S34
artikel
48 IPH4102 in relapsed/refractory cutaneous T cell lymphoma (CTCL): Results of the first-in-human multicenter phase 1 study Bagot, Martine
2018
101 S1 p. S29
artikel
49 KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia (ATLL) Hurabielle, Charlotte
2018
101 S1 p. S7-S8
artikel
50 Levels of IL-31 in different variants of cutaneous T cell lymphomas van Santen, Suzanne
2018
101 S1 p. S17
artikel
51 Long-term complete remission induced by mogamulizumab in a severe Sezary patient, together with five different possible auto-immune manifestations Bagot, Martine
2018
101 S1 p. S22
artikel
52 Long-term remission of relapsed subcutaneous panniculitis-like T-cell lymphoma with cyclosporine A: A case report Onida, Francesco
2018
101 S1 p. S24
artikel
53 Lymph node imaging in patch/plaque mycosis fungoides; enlarged LN are infrequent but lymphomatous nodal involvement may occur and upstage patients to advanced disease Hodak, Emmilia
2018
101 S1 p. S25-S26
artikel
54 Lymphocytoma cutis arising in generalized morphea: A case report Dairi, Motaz
2018
101 S1 p. S20-S21
artikel
55 Managing HRQL in patients with CTCL: Physician responses from the 2018 USCLC Workshop Zic, John
2018
101 S1 p. S38
artikel
56 Metabolic dynamics control invasion and dissemination of cutaneous T-cell lymphoma Schieke, Stefan
2018
101 S1 p. S5-S6
artikel
57 Methylation analysis in Sézary syndrome and integration of exome and transcriptome data Rabionet, Raquel
2018
101 S1 p. S13-S14
artikel
58 Mortality in mycosis fungoides: Evaluation of prognostic markers and models in 58 patients Porkert, Stefanie
2018
101 S1 p. S29-S30
artikel
59 Mutations in highly conserved phosphatase PP5 identified in CTCL lead to dysregulation of the MAPK pathway Flanagan, Charlotte
2018
101 S1 p. S14
artikel
60 Mycosis fungoides, insights in the latest therapy options and the possibility of a promising use of helical tomotherapy Smitt, Johanna Sillevis
2018
101 S1 p. S31
artikel
61 Not everything that looks like a bruise, is a bruise … Silzle, Tobias
2018
101 S1 p. S26-S27
artikel
62 Overcoming cell death resistance in cutaneous T cell lymphoma (CTCL) by combined Bcl-2 and NFκB inhibition Schlör, Tabea
2018
101 S1 p. S29
artikel
63 1p36 deletion is associated with TNFRSF14 mutations in primary cutaneous follicle center lymphoma Bátai, Bence
2018
101 S1 p. S11
artikel
64 Pediatric mycosis fungoides: Management and outcomes with special focus on the folliculotropic variant Hodak, Emmilia
2018
101 S1 p. S33-S34
artikel
65 Pembrolizumab in mycosis fungoides and Sézary syndrome: Updated results of the CITN multicenter Phase 2 study Khodadoust, Michael S.
2018
101 S1 p. S37
artikel
66 Phase 1, single-arm, open-label, dose escalation trial of microneedle array-doxorubicin in patients with mycosis fungoides Akilov, Oleg
2018
101 S1 p. S32
artikel
67 Primary cutaneous anaplastic large cell lymphoma (pcALCL): Initial approach and long-term follow-up in 108 patients. Fernández-de-Misa, Ricardo
2018
101 S1 p. S19-S20
artikel
68 Primary cutaneous CD8+ CD30+ lymphoproliferative disorder in a patient with acquired CD4 immunodeficiency Pileri, Alessandro
2018
101 S1 p. S24-S25
artikel
69 Primary cutaneous diffuse large B cell lymphoma, not otherwise specified, germinal center type–Case report Ibrahim, Mona
2018
101 S1 p. S17-S18
artikel
70 Primary cutaneous gamma/delta T-cell lymphoma: A case report Muresan, Ana-Maria
2018
101 S1 p. S21
artikel
71 Primary cutaneous ‘indolent’ epidermotropic cytotoxic T-cell lymphoma Estrach, Teresa
2018
101 S1 p. S22
artikel
72 Primary cutaneous marginal zone lymphoma with unusual clinical characteristics: Large cell transformation and associations with DLBCL and AITL Marschalko, Marta
2018
101 S1 p. S27-S28
artikel
73 Prognostic miRNA classifier in early-stage mycosis fungoides: Development and validation in a Danish nationwide study Lindahl, Lise M.
2018
101 S1 p. S10
artikel
74 Quality of life in cutaneous T cell lymphoma patients treated with the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from MAVORIC Porcu, Pierluigi
2018
101 S1 p. S38-S39
artikel
75 Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement Molloy, Kevin
2018
101 S1 p. S39
artikel
76 Reduced intensity allogeneic stem cell transplantation for advanced stage mycosis fungoides and Sezary syndrome. A series of 53 patients from the UK. Morris, Stephen
2018
101 S1 p. S36
artikel
77 Resminostat affects transcriptional regulation of disease-related processes in CTCL Bretz, Anne Catherine
2018
101 S1 p. S2
artikel
78 Resminostat for maintenance treatment of patients with advanced stage mycosis fungoides (MF) or Sézary syndrome (SS)–A status update Stadler, Rudolf
2018
101 S1 p. S28-S29
artikel
79 Results of helical tomotherapy on mycosis fungoides lesions Smitt, Johanna Sillevis
2018
101 S1 p. S31
artikel
80 Revisiting blood classification in Mycosis Fungoides and Sézary syndrome with the KIR3DL2 marker Moins-Teisserenc, Helene
2018
101 S1 p. S10-S11
artikel
81 Risk factors for surgical site infections are different in patients with cutaneous T cell lymphoma and melanoma Sproll, Melanie Susanne
2018
101 S1 p. S32
artikel
82 Selective inhibition of HDAC6 sensitizes CTCL to PI3K inhibitors Bobrowicz, Malgorzata
2018
101 S1 p. S9-S10
artikel
83 Sezary syndrome: A single center retrospective study with proposal for a clinical score system Quaglino, Pietro
2018
101 S1 p. S21-S22
artikel
84 Sezary syndrome, 3 injections of alemtuzumab may suffice Gaide, Olivier
2018
101 S1 p. S32
artikel
85 Single-cell variability drives phenotypic heterogeneity and intrinsic drug-resistance in cutaneous T-cell lymphoma Schieke, Stefan
2018
101 S1 p. S5
artikel
86 Spongiotic mycosis fungoides: Several cases of a rare variant of cutaneous T cell lymphoma Junkins-Hopkins, Jacqueline
2018
101 S1 p. S28
artikel
87 Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple lesions Fujii, Kazuyasu
2018
101 S1 p. S18
artikel
88 Standardized flow cytometry (EuroFlow) demonstrates heterogeneous T-cell origin of Sézary lymphoma cells Najidh, Safa
2018
101 S1 p. S8
artikel
89 Survival rates and hematological parameters of Sezary syndrome treated with chlorambucil or interferon: An acceptable alternative when photopheresis is not available? Cury-Martins, Jade
2018
101 S1 p. S35
artikel
90 T-cell receptor clonality analysis with the Biomed-2 PCR as a diagnostic tool in cutaneous T-cell lymphomas Kresbach, Hanna
2018
101 S1 p. S11
artikel
91 T-cell repertoire next generation sequencing of skin and blood in patients with mycosis fungoides Wehkamp, Ulrike
2018
101 S1 p. S4-S5
artikel
92 ‘T-cell versus T-cell’: Tumour infiltrating lymphocytes in mycosis fungoides show a remarkably homogeneous exhaustion profile across a heterogeneous patient population Murray, Duncan
2018
101 S1 p. S11-S12
artikel
93 The assessment of immune-regulatory effects of extracorporeal photopheresis in leukemic cutaneous T cell lymphoma, graft-versus-host disease and lung transplant rejection Schläpfer, Tanja
2018
101 S1 p. S14
artikel
94 The bioactive content of CTCL cell line-derived exosomes and small microvesicles: First study in CTCL Moyal, Lilach
2018
101 S1 p. S4
artikel
95 The experience of patients with cutaneous T-cell lymphoma who have undergone an allogeneic stem cell transplant: A phenomenological study. Morgans, Cath
2018
101 S1 p. S40
artikel
96 The impact of skin infection on quality of life in patients with mycosis fungoides and Sezary syndrome Peng, Chenjing
2018
101 S1 p. S38
artikel
97 The PROCLIPI study; a prototype registry for rare disease with global collaboration for establishment of a prognostic index in mycosis fungoides and Sezary syndrome Scarisbrick, Julia
2018
101 S1 p. S6
artikel
98 The regulation of PD-L1 expression by miRNAs in cutaneous T-cell lymphoma Querfeld, Christiane
2018
101 S1 p. S9
artikel
99 The role of immune-checkpoints in mycosis fungoides Pileri, Alessandro
2018
101 S1 p. S2
artikel
100 The tumour phenotype of mycosis fungoides clusters into three heterogeneous surface expression profiles Murray, Duncan
2018
101 S1 p. S12
artikel
101 The use of PET-CT in detecting histologically confirmed lymphomatous nodes in cutaneous T-cell lymphoma (CTCL): A cohort study from a Tertiary Skin Lymphoma Service Ganatra, Bella
2018
101 S1 p. S27
artikel
102 TOX expression in patients with Mycosis fungoides- a potential diagnostic marker? Nielsen, Pia Rude
2018
101 S1 p. S9
artikel
103 Translational research with topical calcineurin inhibitors in early MF Maroñas-Jiménez, Lidia
2018
101 S1 p. S36
artikel
104 Treatment of early-stage mycosis fungoides: Results from the PROCLIPI study Quaglino, Pietro
2018
101 S1 p. S34
artikel
105 Tumor clone frequency is a robust predictor of progression and survival in patients with Stage IB mycosis fungoides De Masson, Adele
2018
101 S1 p. S1
artikel
106 Understanding the tumor microenvironment in the primary cutaneous CD30-positive lymphoproliferative disorders Ferreira, Cristiane
2018
101 S1 p. S1-S2
artikel
107 Updated combined analysis of two phase II studies of brentuximab vedotin in patients with mycosis fungoides and Sézary syndrome Huen, Auris
2018
101 S1 p. S37
artikel
108 Updates from the central pathology review in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) for the Global PROCLIPI study Gru, Alejandro
2018
101 S1 p. S16-S17
artikel
109 Upregulation of integrin-associated protein on tumor T cells in CTCL inhibits IL-12 and Th1 immunity Ignatova, Desislava
2018
101 S1 p. S6-S7
artikel
110 Using target capture based high throughput DNA sequencing methodology to identify T-cell receptor sequences in mycosis fungoides Iyer, Aishwarya
2018
101 S1 p. S3
artikel
                             110 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland